-
公开(公告)号:US09758593B2
公开(公告)日:2017-09-12
申请号:US11788808
申请日:2007-04-20
CPC分类号: C07K16/44 , A61K2039/505 , C07K2317/24 , C07K2317/92
摘要: Methods for treating a cocaine-related disorder in an individual include administering to the individual a therapeutic amount of an antibody comprising a human immunoglobulin gamma heavy chain and a murine lambda light chain. In another embodiment, the light chain includes a human kappa light chain at least partially derived from 1B3. Other embodiments are directed toward the antibodies themselves and methods of binding the antibodies.
-
公开(公告)号:US20120253839A1
公开(公告)日:2012-10-04
申请号:US13433914
申请日:2012-03-29
申请人: Kristi Innocenti Berzansky , Binny John , Hamsa Konanur , David Barber , Paras Desai , Kruti Goswami , Denise Williams , Shabari Madappa
发明人: Kristi Innocenti Berzansky , Binny John , Hamsa Konanur , David Barber , Paras Desai , Kruti Goswami , Denise Williams , Shabari Madappa
IPC分类号: G06Q50/22
摘要: Systems and methods for managing medical information for medical service providers are provided. Personnel are able to manage and track workflow operations, evaluate profitability, and maintain records in an integrated and streamlined manner by executing various modules of a software application. A Dashboard module provides a unitary display of information regarding employee efficiency and operational profitability; a Virtual Will Call module allows for the virtual placement of items in storage areas reflecting the corresponding physical will call storage locations; an Rx Tracker module provides information regarding the status of prescriptions as they go through the process from ordered to dispensed; the Maintenance module allows personnel to define customized delivery methods; and the Archive Viewer module provides a way for personnel to archive images in any accessible drive or memory device, including portable storage media, and to view such images independently of the module using an archive viewer executable.
-
公开(公告)号:US08173779B2
公开(公告)日:2012-05-08
申请号:US12941617
申请日:2010-11-08
申请人: Yan Wang , Robert Greenberg , Leonard Presta , Jonathan A. Pachter , Judith Hailey , Peter Brams , Denise Williams , Mohan Srinivasan , Diane Feingersh
发明人: Yan Wang , Robert Greenberg , Leonard Presta , Jonathan A. Pachter , Judith Hailey , Peter Brams , Denise Williams , Mohan Srinivasan , Diane Feingersh
IPC分类号: C12P21/08
CPC分类号: C07K16/2863 , A61K2039/505 , C07K16/2869 , C07K2317/21 , C07K2317/24 , C07K2317/56 , C07K2317/565 , C07K2317/73 , C07K2317/76
摘要: The present invention includes fully human, neutralizing, monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1). The antibodies are useful for treating or preventing cancer in a subject. Also included are methods of using and producing the antibodies of the invention.
摘要翻译: 本发明包括针对人胰岛素样生长因子受体-I(IGFR1)的完全人,中和的单克隆抗体。 抗体可用于治疗或预防受试者的癌症。 还包括使用和产生本发明的抗体的方法。
-
公开(公告)号:US20070059305A1
公开(公告)日:2007-03-15
申请号:US11598618
申请日:2006-11-13
申请人: Yan Wang , Robert Greenberg , Leonard Presta , Jonathan Pachter , Judith Hailey , Peter Brams , Denise Williams , Mohan Srinivasan , Diane Feingersh
发明人: Yan Wang , Robert Greenberg , Leonard Presta , Jonathan Pachter , Judith Hailey , Peter Brams , Denise Williams , Mohan Srinivasan , Diane Feingersh
IPC分类号: A61K39/395 , C07H21/04 , C12P21/06 , C12N5/06
CPC分类号: C07K16/2863 , A61K2039/505 , C07K16/2869 , C07K2317/21 , C07K2317/24 , C07K2317/56 , C07K2317/565 , C07K2317/73 , C07K2317/76
摘要: The present invention includes fully human, neutralizing, monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1). The antibodies are useful for treating or preventing cancer in a subject. Also included are methods of using and producing the antibodies of the invention.
-
公开(公告)号:US08670999B2
公开(公告)日:2014-03-11
申请号:US13433914
申请日:2012-03-29
申请人: Kristi Innocenti Berzansky , Denise Williams , Binny John , Kruti Goswami , Paras Desai , Shabari Madappa , Hamsa Konanur , David Barber
发明人: Kristi Innocenti Berzansky , Denise Williams , Binny John , Kruti Goswami , Paras Desai , Shabari Madappa , Hamsa Konanur , David Barber
摘要: Systems and methods for managing medical information for medical service providers are provided. Personnel are able to manage and track workflow operations, evaluate profitability, and maintain records in an integrated and streamlined manner by executing various modules of a software application. A Dashboard module provides a unitary display of information regarding employee efficiency and operational profitability; a Virtual Will Call module allows for the virtual placement of items in storage areas reflecting the corresponding physical will call storage locations; an Rx Tracker module provides information regarding the status of prescriptions as they go through the process from ordered to dispensed; the Maintenance module allows personnel to define customized delivery methods; and the Archive Viewer module provides a way for personnel to archive images in any accessible drive or memory device, including portable storage media, and to view such images independently of the module using an archive viewer executable.
摘要翻译: 提供了医疗服务提供者医疗信息管理系统和方法。 人员能够通过执行软件应用程序的各种模块来管理和跟踪工作流操作,评估盈利能力以及以集成和简化的方式维护记录。 仪表板模块提供有关员工效率和运营盈利能力的信息的统一显示; 虚拟呼叫模块允许在反映相应物理的存储区域中的项目的虚拟放置将调用存储位置; Rx跟踪器模块提供关于处方从订购到分发的过程中的状态的信息; 维护模块允许人员定义定制的交货方式; 并且存档查看器模块为人员提供了在任何可访问的驱动器或存储设备(包括便携式存储介质)中归档映像的方式,并使用归档查看器可执行文件独立于模块来查看这些图像。
-
公开(公告)号:US07741449B2
公开(公告)日:2010-06-22
申请号:US11009410
申请日:2004-12-10
IPC分类号: C07K16/00 , C07K16/24 , A61K39/395
CPC分类号: C07K16/249 , A61K51/1021 , A61K2039/505 , C07K16/24 , C07K2317/21 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/74 , C07K2317/76
摘要: The present invention provides isolated anti-interferon alpha monoclonal antibodies, particularly human monoclonal antibodies, that inhibit the biological activity of multiple interferon (IFN) alpha subtypes but do not substantially inhibit the biological activity of IFN alpha 21 or the biological activity of either IFN beta or IFN omega. Immunoconjugates, bispecific molecules and pharmaceutical compositions comprising the antibodies of the invention are also provided. The invention also provides methods for inhibiting the biological activity of IFN alpha using the antibodies of the invention, as well as methods of treating disease or disorders mediated by IFN alpha, such as autoimmune diseases, transplant rejection and graft versus host disease, by administering the antibodies of the invention.
摘要翻译: 本发明提供分离的抗干扰素α单克隆抗体,特别是人单克隆抗体,其抑制多种干扰素(IFN)α亚型的生物学活性,但基本上不抑制IFNα21的生物活性或IFNβ的生物学活性 或IFNγ。 还提供了免疫偶联物,双特异性分子和包含本发明抗体的药物组合物。 本发明还提供了使用本发明的抗体抑制IFNα的生物学活性的方法,以及通过施用本发明的抗体来治疗由IFNα介导的疾病或病症的方法,例如自身免疫疾病,移植排斥反应和移植物抗宿主病 本发明的抗体。
-
公开(公告)号:US07667021B2
公开(公告)日:2010-02-23
申请号:US11598618
申请日:2006-11-13
申请人: Yan Wang , Robert Greenberg , Leonard Presta , Jonathan A. Pachter , Judith Hailey , Peter Brams , Denise Williams , Mohan Srinivasan , Diane Feingersh
发明人: Yan Wang , Robert Greenberg , Leonard Presta , Jonathan A. Pachter , Judith Hailey , Peter Brams , Denise Williams , Mohan Srinivasan , Diane Feingersh
CPC分类号: C07K16/2863 , A61K2039/505 , C07K16/2869 , C07K2317/21 , C07K2317/24 , C07K2317/56 , C07K2317/565 , C07K2317/73 , C07K2317/76
摘要: The present invention includes isolated nucleic acids encoding fully human, neutralizing, monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1). Also included are methods of using and producing the antibodies of the invention.
摘要翻译: 本发明包括编码针对人胰岛素样生长因子受体-I(IGFR1)的完全人,中和的单克隆抗体的分离的核酸。 还包括使用和产生本发明的抗体的方法。
-
公开(公告)号:US20080014197A1
公开(公告)日:2008-01-17
申请号:US11835791
申请日:2007-08-08
申请人: Yan Wang , Robert Greenberg , Leonard Presta , Jonathan Pachter , Judith Hailey , Peter Brams , Denise Williams , Mohan Srinivasan , Diane Feingersh
发明人: Yan Wang , Robert Greenberg , Leonard Presta , Jonathan Pachter , Judith Hailey , Peter Brams , Denise Williams , Mohan Srinivasan , Diane Feingersh
IPC分类号: A61K39/395 , A61P35/00 , A61P9/10 , C07K16/22
CPC分类号: C07K16/2863 , A61K2039/505 , C07K16/2869 , C07K2317/21 , C07K2317/24 , C07K2317/56 , C07K2317/565 , C07K2317/73 , C07K2317/76
摘要: The present invention includes fully human, neutralizing, monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1). The antibodies are useful for treating or preventing cancer in a subject. Also included are methods of using and producing the antibodies of the invention.
摘要翻译: 本发明包括针对人胰岛素样生长因子受体-I(IGFR1)的完全人,中和的单克隆抗体。 抗体可用于治疗或预防受试者的癌症。 还包括使用和产生本发明的抗体的方法。
-
公开(公告)号:US07217796B2
公开(公告)日:2007-05-15
申请号:US10443466
申请日:2003-05-22
申请人: Yan Wang , Robert Greenberg , Leonard Presta , Jonathan A. Pachter , Judith Hailey , Peter Brams , Denise Williams , Mohan Srinivasan , Diane Feingersh
发明人: Yan Wang , Robert Greenberg , Leonard Presta , Jonathan A. Pachter , Judith Hailey , Peter Brams , Denise Williams , Mohan Srinivasan , Diane Feingersh
IPC分类号: A61K39/395
CPC分类号: C07K16/2863 , A61K2039/505 , C07K16/2869 , C07K2317/21 , C07K2317/24 , C07K2317/56 , C07K2317/565 , C07K2317/73 , C07K2317/76
摘要: The present invention includes fully human, neutralizing, monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1). The antibodies are useful for treating or preventing cancer in a subject. Also included are methods of using and producing the antibodies of the invention.
摘要翻译: 本发明包括针对人胰岛素样生长因子受体-I(IGFR1)的完全人,中和的单克隆抗体。 抗体可用于治疗或预防受试者的癌症。 还包括使用和产生本发明的抗体的方法。
-
公开(公告)号:US3965375A
公开(公告)日:1976-06-22
申请号:US560332
申请日:1975-03-21
CPC分类号: G02F1/3551
摘要: The nonlinear properties of LiClO.sub.4.3H.sub.2 O permit noncritical phase matching in the vicinity of 5200 Angstroms at room temperature. This material may be used as the essential element in second harmonic generators and other nonlinear devices which could then be operated at room temperature under noncritical phase-matched conditions.
摘要翻译: LiClO4.3H2O的非线性特性允许在室温下在5200埃附近进行非临界相匹配。 这种材料可以用作二次谐波发生器和其他非线性装置中的基本元件,然后可以在室温下在非临界相位匹配条件下操作。
-
-
-
-
-
-
-
-
-